1Jemal A, Timari RC, Murray, et al. Cancer statistics, 2004. CA Cancer J Clin,2004,54:8-29.
2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin ,2005,55:74-108.
3Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem, 1996,72:248-254.
4Thompson S, Dargan E, Turner GA. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett, 2002,66 : 43 -48.
5Ye B,Cramer DW, Skates SJ, et al. Haptoglobin-alphasu bunit as potential serum biomarker in ovarian cancer: identification and characteri- zation using pmteomic profihng and mass spectrometry. Clin Cancer Res, 2003,9:2904-2911.
4Hu S,Arellano M,Boontheung P,et al.Salivary pro-teomics for oral cancer biomarker discovery[J].ClinCancer Res,2008,14(19):6246-6252.
5Schaaij-Visser TB,Graveland AP,Gauci S,et al.Differen-tial proteomics identifies protein biomarkers that predictlocal relapse of head and neck squamous cell carcinomas[J].Clin Cancer Res,2009,15(24):7666-7675.
6Mlynarek AM,Balys RL,Su J,et al.A cell proteomic ap-proach for the detection of secretable biomarkers of inva-siveness in oral squamous cell carcinoma[J].Arch Otola-ryngol Head Neck Surg,2007,133(9):910-918.
